Trial Condition(s):
Safety Trial of Naproxen Sodium/ Diphenhydramine (MUST)
15560
Not Available
Not Available
The purpose of this trial is to see how safe the combination of naproxen sodium 440 mg and diphenhydramine hydrochloride (DPH) 50 mg (the investigational product) is compared to placebo (capsules containing no drug) when taken for 10 days.
- Healthy, ambulatory, male and female volunteers ages 12 and older - History of experiencing occasional sleeplessness accompanied by aches and pains at least two times, but not continually for more than 14 days per month, in at least 2 of the past 3 months - Female subjects of childbearing potential must be using a medically acceptable form of birth control, e.g., oral or patch contraceptives, intrauterine device, Depo-Provera®, for at least 1 month prior to screening (3 months on oral contraceptives), or double-barrier and have a negative pregnancy test at Screening. Female subjects of nonchildbearing potential must be amenorrheic for at least 2 years or have had a hysterectomy and/or bilateral oophorectomy - Be willing and able to participate in all scheduled visits, treatment plan, tests and other trial procedures according to the protocol - Provide a personally signed and dated informed consent indicating that the subject has been informed of all pertinent aspects of the trial, (subjects <18 years of age must sign a written assent and have parental or guardian consent).
- History of hypersensitivity to naproxen sodium, acetaminophen, or any NSAIDs (Nonsteroidal Antiinflammatory Drugs), diphenhydramine or any other antihistamines, and similar pharmacological agents or components of the product - Evidence or history of clinically significant (in the judgment of the investigator) hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic diseases, or malignancies with the last 5 years - A history of a chronic or severe sleep problem which does not respond to OTC (Over-the-counter) medication and/or requires a prescription hypnotic or sedative - Currently experiencing chronic pain or on chronic NSAID therapy (defined as taking a daily [5 to 7 days per week] regimen of prescription or OTC NSAIDs) - Current or past history of gastrointestinal ulcers or bleeding or other bleeding disorders - Use of any OTC or prescription medications with which the administration of naproxen, acetaminophen, or any NSAIDs, diphenhydramine or any other antihistamines or sedatives, is contraindicated - Chronic use of other products containing diphenhydramine, including topical products - Use of steroids or blood thinning (anticoagulant) drugs (aspirin 81 mg is permitted if the dose has been taken for at least one month prior to screening)
Locations | |
---|---|
Locations Rancho Cucamonga Clinical Trials, Inc. Rancho Cucamonga, United States, 91730 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations FPA Clinical Research Kissimmee, United States, 34741 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations East Valley Family Physicians, PLC Chandler, United States, 85224 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Mesa Family Medical Center Mesa, United States, 85203 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Omega Medical Research Warwick, United States, 02886 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Centennial Medical Group Elkridge, United States, 21075 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Benchmark Research San Angelo, United States, 76904 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Benchmark Research Metairie, United States, 70006 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Miami Research Associates South Miami, United States, 33143 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Integra Clinical Research, LLC San Antonio, United States, 78231 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Benchmark Research Sacramento, United States, 95816 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Clinical Research Atlanta Stockbridge, United States, 30281 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Benchmark Research Fort Worth, United States, 76135 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Colorado Springs Health Partners, PC Colorado Springs, United States, 80922 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Coastal Carolina Research Center Mt. Pleasant, United States, 29464 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Premier Research Group Peoria, United States, 85381 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Lifetree Clinical Research Salt Lake City, United States, 84106 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Advanced Clinical Research Institute Anaheim, United States, 92801 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Pines Clinical Research Pembroke Pines, United States, 33028 | Contact Us: E-mail: [email protected] Phone: Not Available |
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Safety and Tolerability Trial of Naproxen Sodium/ Diphenhydramine Combination in an OTC Population
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Other
Allocation:
Randomized
Blinding:
Double Blind
Assignment:
Parallel Assignment
Trial Arms:
2